0.4349
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
14.92%
2.5925
|
2.2559 | 2.4983 | 3.1238 | 1.7142 |
| Operating Income/Loss |
14.92%
-2.5925
|
-2.2559 | -2.4983 | -3.1238 | -1.7142 |
| Nonoperating Income/Loss |
45.59%
0.0174
|
0.0321 | 0.0745 | 0.0572 | -0.5578 |
| Income/Loss From Continuing Operations Before Tax |
15.79%
-2.5751
|
-2.2239 | -2.217 | -3.0666 | -2.272 |
| Income Tax Expense/Benefit |
104.98%
-0.0464
|
-0.0226 | - | - | - |
| Net Income/Loss |
14.88%
-2.5287
|
-2.2012 | -2.2869 | -3.0666 | -2.272 |
| Basic Average Shares |
2.97%
4.4286
|
4.301 | 18.22 | 1.5609 | 0.7318 |
| Diluted Average Shares |
2.97%
4.4286
|
4.301 | 18.22 | 1.5609 | 0.7318 |
| Basic Earnings Per Share |
11.76%
-0.57
|
-0.51 | -0.12 | -1.96 | -3.10 |
| Diluted Earnings Per Share |
11.76%
-0.57
|
-0.51 | -0.12 | -1.96 | -3.10 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):